Recent News

September 15-18, 2014: ChemOutsourcing 2014
PCAS-Nanosyn with be at ChemOutsourcing 2014 in Long Branch, NJ. ChemOutsourcing is the largest USA-based API show attracting 700-800 chemists from the pharmaceutical, biotech, and chemical industries, focused on API development spanning early drug discovery through chemical development and commercial supply.

October 7-9, 2014: CPhI Worldwide
Mix with the world of Pharma, products, people & solutions at CPhI Worldwide in Paris Nord Villepinte, France. Meet face-to-face with over 2,200 exhibitors and 34,000 attendees from 140 countries representing international pharmaceutical companies and CMO's. Stay informed about the latest industry trends and remain one step ahead of a constantly changing pharmaceutical market.

Please contact James Faust ( to schedule a meeting at any of these events or to discover how PCAS-Nanosyn can bridge the gap between Discovery and Commercialization.

Drug Discovery to Commercialization

PCAS-Nanosyn is designed to bridge the capabilities of the two parent companies and offer a seamless transition to pharmaceutical and biotech customers for custom chemical services from discovery chemistry and biology at Nanosyn through to commercial scale API and fine chemical production at PCAS. The excellent quality systems and kilolab scale capabilities of the JV are also a great fit to serve the scale-up and commercial needs for other business segments, such as medical devices, diagnostics, and semi-conductors.

The primary site of the JV is a R&D and cGMP kilolab in Santa Rosa, CA, north of San Francisco in the heart of Sonoma County wine country, that has a 30-year experience base as a FDA registered facility. With six, separate cGMP suites with walk-in hoods, including two, certified Class 10,000 clean rooms, coupled with R&D and analytical testing capabilities that have recently undergone significant upgrades, the site combines small company personal service and flexibility with large company derived expertise for process identification, development, scale-up, analytical methods development and testing, and manufacture under cGMP protocols.